CURE EPILEPSY – Competitive LOI’s

Catalyst Award

Prioritizes projects that advance research to clinical trial readiness. This includes the development of biomarkers and optimization of promising new entities with established proof-of-concept to improve pharmacokinetics/pharmacodynamics, safety profiles, and/or formulations to advance these new entities further in development.

Funding: max of $120K for 1 year (No Overhead)

https://www.trdf.co.il/files/CATALYST AWARD.pdf

Rare Epilepsy Partnership Award

An overarching goal of this funding mechanism is to develop resources and data that will be made available to the research community to accelerate research on rare epilepsies.

Funding: max of $100K for 1 year (No Overhead)

https://www.trdf.co.il/files/REPA-Guidelines_Final.pdf